2014 News

11 November 2014

Abzena's CEO Dr John Burt talks to Cambridge Business about the company’s recent floatation on AIM and its unusual business model.

Abzena's CEO Dr John Burt talks to Cambridge Business about the company’s recent floatation on AIM and its unusual business model.

Read the full article here:

http://www.cambridge-news.co.uk/Biotech-big-time-Abzena-s-riding-high/story-24099284-detail/story.html

From our portfolio

Arlabion

Biotechnology

Arlabion is an agri-tech company developing a novel seed treatment to protect crops against funga...

viewview our portfolio

Our Team

Rob Carroll

view complete team

Contact us

Binder House
7 Narborough Wood Park
Desford Road
Enderby
Leicester
LE19 4XT

Tel: 0116 238 8200

email